Prime Medicine Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
/ 
Frequently asked questions
To buy Prime Medicine Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Prime Medicine Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Prime Medicine Inc. is PRME:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Prime Medicine Inc. has its primary listing on NASDAQ. You can trade Prime Medicine Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Prime Medicine Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Prime Medicine Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Prime Medicine Inc. or others.